Literature DB >> 10564713

Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A-->G mutation in mitochondrial DNA.

H Rusanen1, K Majamaa, I E Hassinen.   

Abstract

The MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) is most commonly caused by the 3243A-->G mutation in mitochondrial DNA, resulting in impaired mitochondrial protein synthesis and decreased activities of the respiratory chain complexes. These defects may cause a reduced capacity for ATP synthesis and an increased rate of production of reactive oxygen species. Myoblasts cultured from controls and patients carrying the 3243A-->G mutation were used to measure ATP, ADP, catalase and superoxide dismutase, which was also measured from blood samples. ATP and ADP concentrations were decreased in myoblasts with the 3243A-->G mutation, but the ATP/ADP ratio remained constant, suggesting a decrease in the adenylate pool. The superoxide dismutase and catalase activities were higher than in control cells, and superoxide dismutase activity was slightly, but not significantly higher in the blood of patients with the mutation than in controls. We conclude that impairment of mitochondrial ATP production in myoblasts carrying the 3243A-->G mutation results in adenylate catabolism, causing a decrease in the total adenylate pool. The increase in superoxide dismutase and catalase activities could be an adaptive response to increased production of reactive oxygen species due to dysfunction of the mitochondrial respiratory chain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10564713     DOI: 10.1016/s0925-4439(99)00081-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes.

Authors:  Shingo Kariya; Nobuyuki Takahashi; Makito Hirano; Satoshi Ueno
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

2.  Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation.

Authors:  Jagdeep K Sandhu; Caroline Sodja; Kevan McRae; Yan Li; Peter Rippstein; Yau-Huei Wei; Boleslaw Lach; Fay Lee; Septimiu Bucurescu; Mary-Ellen Harper; Marianna Sikorska
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

3.  Phosphorylation of DYNLT1 at serine 82 regulates microtubule stability and mitochondrial permeabilization in hypoxia.

Authors:  Xue Xu; Qiong Zhang; Jiong-yu Hu; Dong-xia Zhang; Xu-pin Jiang; Jie-zhi Jia; Jing-ci Zhu; Yue-sheng Huang
Journal:  Mol Cells       Date:  2013-10-22       Impact factor: 5.034

Review 4.  Oxidative stress in inherited mitochondrial diseases.

Authors:  Genki Hayashi; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

Review 5.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 6.  Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome.

Authors:  Shi-Bei Wu; Yi-Shing Ma; Yu-Ting Wu; Yin-Chiu Chen; Yau-Huei Wei
Journal:  Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.590

7.  Gene expression profiling of skeletal muscle in exercise-trained and sedentary rats with inborn high and low VO2max.

Authors:  Anja Bye; Morten A Høydal; Daniele Catalucci; Mette Langaas; Ole Johan Kemi; Vidar Beisvag; Lauren G Koch; Steven L Britton; Øyvind Ellingsen; Ulrik Wisløff
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

Review 8.  Mitochondrial disease: mutations and mechanisms.

Authors:  Matthew McKenzie; Danae Liolitsa; Michael G Hanna
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

9.  Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke.

Authors:  Chaya G Bhuvaneswar; Jared L Goetz; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.

Authors:  Kirsi Majamaa-Voltti; Keijo Peuhkurinen; Marja-Leena Kortelainen; Ilmo E Hassinen; Kari Majamaa
Journal:  BMC Cardiovasc Disord       Date:  2002-08-01       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.